+34
Singapore will include the HPV9 vaccine in its national immunisation schedules from Jan 1, 2027, offering broader protection against cervical cancer and replacing HPV2 in school programmes.
Singapore will add the HPV9 vaccine to its national immunisation schedules from Jan 1, 2027. The Ministry of Health, Health Promotion Board and Communicable Diseases Agency announced this in a joint statement on Oct 2.
HPV9 Coverage and Dosage Updates
HPV9, also known as Gardasil 9, will be included in the National Childhood Immunisation Schedule and the National Adult Immunisation Schedule for females aged 9 to 26. It will also be added to the subsidised vaccine list. The vaccine offers broader protection against cervical cancer, covering HPV types responsible for about 90 per cent of all cervical cancers. HPV2, known as Cervarix, protects against about 70 per cent and will remain on both schedules as an alternative option.
HPV4, previously known as Gardasil, is no longer available in Singapore and has been removed from the national schedules. The current HPV2 vaccine will also be replaced by HPV9 for female students who have yet to start or complete their series from Jan 1, 2027. The Expert Committee on Immunisation has updated its HPV vaccination recommendations. Unvaccinated females can start or complete their series with either HPV2 or HPV9.
Those receiving their first dose between ages 9 and 14 require two doses, while those starting between 15 and 26 require three doses. If vaccination is initiated but not completed by age 26, the remaining doses may be taken after age 26, as early as possible, up to age 45. This includes females aged 27 to 45 who want to complete the series.
Adult Vaccination and Schedule Changes
However, the Communicable Diseases Agency said there is currently no recommendation under the NAIS for this group to start HPV vaccination due to limited population-level evidence of efficacy. Females who have started with HPV2 or HPV4 and are pending further doses may complete their series with HPV9. Studies show mixed schedules are safe and provide protection against strains covered by both vaccines.
Those who have completed their schedule do not need additional doses and will not be eligible for extra HPV9 doses. Secondary 1 and 2 girls will receive HPV9 in schools instead of HPV2 from Jan 1, 2027. Female students who received HPV2 as their first dose in 2026, including the 2026 Secondary 1 cohort, will complete their series in schools in 2027 with HPV9 as their second dose.
HPV vaccinations are currently provided at no charge to Secondary 1 and 2 female students. From Jan 1, 2027, eligible Singaporean children will receive full subsidies for HPV9 at CHAS GP clinics and polyclinics. Eligible Singaporean adults will receive means-tested subsidies of up to 75 per cent. Eligible permanent residents will receive subsidies at polyclinics.
Subsidies, MediSave and Booking Options
MediSave use for HPV9 vaccination will be extended to recommended groups under the NCIS and NAIS. This is subject to MediSave Chronic and Preventive Care limits of $700, or $1,000 for patients treated for at least two Chronic Disease Management Programme conditions, or one CDMP condition with complications, within a calendar year. Vaccination subsidies and MediSave will not apply to additional HPV9 doses for those who have completed their recommended schedule.
Women aged 27 or above who have not started HPV vaccination will also not be eligible for subsidies or MediSave, as the vaccine is not recommended under the NAIS for this group. They can still get vaccinated at their own cost. Eligible individuals can book HPV vaccination appointments at participating CHAS GP clinics through the national vaccination booking portal. They can also make an appointment at a polyclinic.
A doctor group has recommended HPV vaccination for men to improve public health in Singapore.
Please follow us on Google to support us
asiaonecom 
straits_times:Eligible women in S’pore to get subsidised access to broader HPV9 vaccine from 2027This story was compiled and edited by the HeadTopics newsroom and HT AI from the reports above.
Cervical Cancer Singapore Immunisation Schedules Gardasil 9 Vaccine Subsidies Singapore Immunisation Schedule Cervical Cancer Prevention Gardasil 9 Subsidies School HPV Vaccination
Singapore Latest News, Singapore Headlines
Similar News: You can also read news stories similar to this one that we have collected from other news sources.
Johor Bahru-Singapore RTS Link Passenger Service to Begin February 2027The Johor Bahru-Singapore RTS Link will start passenger service in February 2027 after all system tests and trial runs are completed by Dec 31, 2026, operator RTS Operations said.
Read more »
Johor Bahru-Singapore RTS Link Passenger Service Delayed to February 2027RTS Operations says all system tests and trial runs will be completed by Dec 31, 2026, with passenger service expected to start in February 2027 pending safety certification and regulatory approval.
Read more »
Singapore Adds HPV9 Vaccine to National Immunisation Schedules from Jan 1, 2027Singapore will include the HPV9 vaccine in its national immunisation schedules from Jan 1, 2027, offering broader protection against cervical cancer to females aged 9 to 26, with new subsidies and MediSave coverage.
Read more »